Skip Navigation

Faculty Directory

Anju Singh, PhD

  • Assistant Scientist

Departmental Affiliations

Contact Information

615 N. Wolfe Street
Room E7410
Baltimore, Maryland 21205



PhD, Hyderabad Central University, 2001
MPhil, Hyderabad Central University, 1996


    1. Singh A, Misra V, Thimmulappa RK, Lee H, Ames S, Hoque MO, Herman JG, Baylin SB, Sidransky D, Gabrielson E, Brock MV  andBiswal S. (2006) Dysfunctional Keap1–Nrf2 interaction in non-small-cell lung cancer. PLoS Medicine3 (10):e420. PMCID:PMC 1584412
    1. Singh A, Boldin-Adamsky S, Thimmulappa RK, Rath SK, Ashush H, Coulter J, Blackford A, Goodman SN, Watson WH, Bunz F, Gabrielson E, Feinstein E and Biswal S.  (2008) RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy. Cancer Res. 68(19):7975-84.  PMCID:PMC 30704
    1. Zhang P*Singh A*, Yegnasubramanian S, Eposi D, Kombairaju P, Bodas M, Bova SG, and Biswal S. (2010) Loss of Keap1 function in Prostate cancer cells causes chemoresistance and radio-resistance and promotes tumor growth. Mol Cancer Ther.; 9(2):336-46. PMCID:PMC 2821808
    1. Singh A, Bodas M, Wakabayashi N, Bunz F and Biswal S. (2010)Gain of Nrf2 function in non–small-cell lung cancer cells confers radioresistance. Antioxid Redox Signal. Dec; 13(11):1627-37. PMCID:PMC 3541552
    1.  Singh  A, Happel C, Manna SK, Acquaah-Mensah G, Carratero J,Kumar S, Nasipuri P, Krausz KW, Wakabayashi N, Dewi R, Boros LG,  Gonzalez F, Gabrielson E, Wong KK, Girnun G, Biswal S. Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest - 123 (7).